pharma news today obesity drugs glp-1 october 2025 2024 was a record year for trials and is already poised to take over Anti-Obesity Drugs Market Report 2025
Description
Hold the pen with the needle pointing down at a 90-degree angle to the skin
A state-by-state look at how affordable GLP-1 drugs like Ozempic and Zepbound really are and where cost keeps patients from access.

The 44-year-old tennis champion said she feels even healthier than she did as a professional athlete.

Overall, the GLP-1 market is expected to experience annual growth exceeding 20% and will hit $133 billion worldwide by 2030, according to a MarketWatch report from February.

These blockbuster medications have been associated with a range of health benefits, but a lack of data about how the drugs impact adults age 65 and up has clini

ColonBroom GLP-1 Booster is a dietary supplement, not a prescription medicationthese are fundamentally